Idera Pharmaceuticals: Rises on clinical trial update, smaller Q3 loss

Aceragen

07/11/2018 18:03

** Drug developer's shares  IDRA.O  up 25 pct at $9.04 
    ** Co says will present clinical data from its cancer
treatment in the first half of December, and posts a smaller Q3
loss  urn:newsml:reuters.com:*:nGNX8TZF4z
    ** More than 790,000 shares traded, about 3.7 times their
25-day moving avg
    ** Including session gains, stock has fallen about 48 pct
YTD

 (Reporting by Manas Mishra in Bengaluru)
 ((Reuters Messaging:
manas.mishra.thomsonreuters.com@reuters.net))